In last trading session, Cabaletta Bio Inc (NASDAQ:CABA) saw 0.62 million shares changing hands with its beta currently measuring 2.74. Company’s recent per share price level of $1.67 trading at -$0.01 or -0.60% at ring of the bell on the day assigns it a market valuation of $150.20M. That closing price of CABA’s stock is at a discount of -360.48% from its 52-week high price of $7.69 and is indicating a premium of 40.72% from its 52-week low price of $0.99. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.82 million shares which gives us an average trading volume of 2.13 million if we extend that period to 3-months.
For Cabaletta Bio Inc (CABA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.36. Splitting up the data highlights that, out of 5 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 5 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Cabaletta Bio Inc (NASDAQ:CABA) trade information
Cabaletta Bio Inc’s shares saw a change of -78.75% in year-to-date performance and have moved -4.02% in past 5-day. Cabaletta Bio Inc (NASDAQ:CABA) showed a performance of -10.46% in past 30-days. Number of shares sold short was 6.47 million shares which calculate 1.92 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 14 to the stock, which implies a rise of 88.07% to its current value. Analysts have been projecting 3 as a low price target for the stock while placing it at a high target of 32. It follows that stock’s current price would drop -79.64% in reaching the projected high whereas dropping to the targeted low would mean a loss of -79.64% for stock’s current value.
Cabaletta Bio Inc (CABA) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -20.35% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -5.33% while estimates for its earnings growth in next 5 years are of 3.54%.
Cabaletta Bio Inc (NASDAQ:CABA)’s Major holders
Insiders are in possession of 2.84% of company’s total shares while institution are holding 68.37 percent of that, with stock having share float percentage of 70.37%. Investors also watch the number of corporate investors in a company very closely, which is 68.37% institutions for Cabaletta Bio Inc that are currently holding shares of the company. JENNISON ASSOCIATES LLC is the top institutional holder at CABA for having 5.55 million shares of worth $41.49 million. And as of 2024-06-30, it was holding 11.2498 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 4.76 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.6469 of outstanding shares, having a total worth of $35.58 million.
On the other hand, T. Rowe Price Small-Cap Value Fund, Inc. and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 1.93 shares of worth $3.23 million or 3.81% of the total outstanding shares. The later fund manager was in possession of 1.4 shares on Mar 31, 2025 , making its stake of worth around $2.34 million in the company or a holder of 2.76% of company’s stock.
